Abstract
The review summarizes literature data on existing pharmacological agents and novel drug preparations developed for correction of dyslipidemias and molecular mechanisms of their action. Much attention is paid to analysis of experimental and clinical studies aimed at identification of new pharmacological targets for correction of dyslipidemias and characterization of approaches increasing high density lipoproteins functionality. The implementation of alternative pharmacological agents with new alternative mechanisms of action may improve the effectiveness of traditional treatment in the future.
Similar content being viewed by others
Abbreviations
- ABCA1:
-
ATP-binding cassette transporter A1
- ABCG1:
-
ATP-binding cassette transporter G1
- ABCG5:
-
ATP-binding cassette transporter G5
- ABCG8:
-
ATP-binding cassette transporter G8
- ACS:
-
acute coronary syndrome
- AP2:
-
Adaptor protein 2
- Apo A-1:
-
apolipoprotein A-1
- Apo B:
-
apolipoprotein B
- BD2:
-
Bromodomain 2
- BET:
-
Bromodomain and extra-terminal domain
- B-PAV:
-
Baseline percent atheroma volume
- CETP:
-
Cholesterol ester transfer protein
- CEC:
-
Cholesterol efflux capacity
- Chol:
-
cholesterol
- CholE:
-
cholesterol esters
- CVDs:
-
cardiovascular diseases
- DGAT2:
-
Diacylglycerol acyltransferase 2
- FA:
-
fatty acids
- FAMP:
-
Fukuoka University ApoA-I Mimetic Peptide
- FXR:
-
Farnesoid X receptor)
- GIT:
-
gastrointestinal tract
- HCA:
-
Hyocholic acid)
- HDCA:
-
Hyodeoxycholic acid
- HDL:
-
high density lipoproteins
- HDL-C:
-
high-density lipoprotein cholesterol
- HDLR:
-
high density lipoprotein receptors
- HMG-CoA reductase:
-
β-hydroxy-β-methyl glutarylcoenzyme A reductase
- LDL:
-
low density lipoproteins
- LDLR:
-
low density lipoprotein receptors
- LDL-C:
-
low-density lipoprotein cholesterol
- LPA:
-
lysophosphatidic acid
- LXR:
-
Liver X receptors
- MACE:
-
Major Adverse Cardiac Events
- MHC II:
-
Major histocompatibility complex class II
- NOS:
-
Nitric oxide synthase
- NPC1L1:
-
Niemann-Pick C1-like 1 protein
- PCh:
-
phosphatidylcholine
- PCSK9:
-
Proprotein convertase subtilisin/kexin type 9
- PL:
-
phospholipids
- PPAR:
-
Peroxisome proliferator-activated receptors
- RCT:
-
reverse cholesterol transport
- SRB1:
-
Scavenger receptor class B member 1
- SREBR-2:
-
Sterol regulatory element- binding protein 2
- TGR5:
-
Transmembrane G protein coupled bile acid receptor
- TG:
-
triglycerides
References
Nelson, R.H., Prim. Care, 2013, vol. 40, no. 1, pp. 195–211.
Diagnostika i korretsiya narusheniy lipidnogo obmena s tsel’yu profilaktiki i lecheniya ateroskleroza (Diagnostics and Correction of Lipid Metabolism Impairments for Prophylaxis and Therapy of Atherosclerosis) Russian Recommendations, VI ed., AiD, 2017, no. 3, pp. 5–22.
Klimov, A.N. and Nikulcheva, N.G., Obmen lipidov i lipoproteidov i ego narusheniya (Metabolism of Lipids and Lipoproteins and its Impairments), Saint Petersburg: Piter, 1999.
Illter, A., Tusun, E., Besli, F., and Sezen, H., Eur. J. Health Sci., 2016, vol. 2, pp. 15–19.
Baigent, C., Blackwell, L., Emberson, J., Holland, L.E., Reith, C., Bhala, N., et al., Lancet, 2010, vol. 376, pp. 1670–1681.
Stoekenbroek, R.M., Stroes, E.S., and Hovingh, G.K., Handbook of Experimental Pharmacology, High Density Lipoproteins, Eckardstein, A. and Kardassis, D., Eds., Springer, 2015, vol. 22, pp 633–643.
Perez-Mendez, O., Arch. Cardiol Mex., 2004, vol. 74, pp. 53–67.
Ikenaga, M., Higaki, Y., Saku, K., and Uehara, Y., J. Atheroscler. Thromb., 2016, vol. 23, pp. 385–394.
Boden, W.E., Probstfield, J.L., Anderson, T., Chaitman, B.R., Desvignes-Nickens, P., et al., N. Engl. J. Med., 2011, vol. 365, pp. 2255–2267.
Nissen, S.E., Tardif, J.C., Nicholls, S.J., Revkin, J.H., Shear, C.L., et al., N. Engl. J. Med., 2007, vol. 356, pp. 1304–1316.
Lim, G.B., Nat. Rev. Cardiol., 2013, vol. 10, 5. doi 10.1038/nrcardio.2012.171
HPS2-THRIVE Collaborative Group, Eur. Heart. J., 2013, vol. 34, pp. 1279–1291.
Keene, D., Price, C., Shun-Shin, M.J., and Francis, D.P., B.M.J., 2014, vol. 349, g4379.
Yamamoto, S., Narito, I., and Kotany, K., Clin. Chim. Acta, 2016, vol. 457, pp. 117–122.
Mani, P. and Rohatgi, A., Curr. Atheroscler. Rep., 2015, vol. 17, no. 8. doi 10.1007/s11883-015-0521-x
Couture, P. and Lamarche, B., Curr. Opin. Lipidol., 2013, vol. 24, pp. 227–232.
Ge, L., Wang, J., Qi, W., et al., Cell Metab., 2008, vol. 7, pp. 508–519.
Shulutko, B.I. and Makarenko, S.V., Standarty diagnostiki i lecheniya vnutrennikh boleznei (Standards of Diagnostics and Therapy of Internal Diseases), 2007.
Joseph, L. and Robinson, J.G., Prog. Cardiovasc. Dis., 2015, vol. 58, no. 1, pp. 19–31.
Cimmino, G., Ciccarelli, G., Morello, A., Ciccarelli, M., and Golino, P., J. Transl. Med., 2015, vol. 2012, no. 6, pp. 29–40.
Gomaraschi, M., Adorni, M.P., Banach, M., Bernini, F., et al., Handbook of Experimental Pharmacology, High Density Lipoproteins, Eckardstein, A. and Kardassis, D., Eds., Springer, 2015, vol. 224, pp. 593–615.
Norato, G.D., Scientifica (Cairo), 2012, vol. 2012, article ID 482423. doi 10.6064/2012/482423
Toth, P.P., Dayspring, T.D., and Pokrywka, G.S., Curr. Atheroscler. Rep., 2009, vol. 11, pp. 71–79.
Ganji, S.H., Tavintharan, S., Zhu, D., Xing, Y., Kamanna, V.S., and Kashyap, M.L., J. Lipid Res., 2004, vol. 45, pp. 1835–1845.
Jin, F.Y., Kamanna, V.S., and Kashyap, M.L., Arterioscler. Thromb. Vasc. Biol., 1999, vol. 19, pp. 1051–1059.
Reiner, Z., Catapano, A.L., Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., et al., Eur. Heart J., 2011, vol. 32, pp. 1769–1818.
Barter, P.J., Caulfield, M., Eriksson, M., Grundy, S.M., Kastelein, J.J., Komajda, M., et al., N. Engl. J. Med., 2007, vol. 357, pp. 2109–2122.
Tchoua, U., Gillard, B.K., and Pownall, H.J., Atherosclerosis, 2010, vol. 209, pp. 430–435.
Jones, P.H., Davidson, M.H., Stein, E.A., Bays, H.E., McKenney, J.M., Miller, E., Cain, V.A., and Blasetto, J.W., Am. J. Cardiol., 2003, vol. 92, pp. 152–160.
Barter, P.J., Brandrup-Wognsen, G., Palmer, M.C., and Nicholls, S.J., J. Lipid Res., 2010, vol. 51, pp. 1546–1553.
Tamehiro, N., Shigemoto-Mogami, Y., Kakeya, T., Okuhira, K., Suzuki, K., Sato, R., Nagao, T., and Nishimaki-Mogami, T., J. Biol. Chem., 2007, vol. 282, pp. 21090–21099.
Kassai, A., Illyes, L., Mirdamadi, H.Z., Seres, I., Kalmar, T., Audikovszky, M., and Paragh, G., Clin. Biochem., 2007, vol. 40, pp. 1–5.
Kwak, B., Mulhaupt, F., Myit, S., and Mach, F., Nat. Med., 2000, vol. 6, pp. 1399–1402.
Mulhaupt, F., Matter, C.M., Kwak, B.R., et al., Cardiovasc. Res., 2003, vol. 59, pp. 755–766.
Haramaki, N., Ikeda, H., Takenaka, K., et al., Arterioscler. Thromb. Vasc. Biol., 2007, vol. 27, pp. 1471–1477.
Xie, C., Zhou, Z.S., Li, N., et al., J. Lipid Res., 2012, vol. 53, pp. 2092–2101.
Phan, B.A., Dayspring, T.D., and Toth, P.P., Vasc. Health Risk Manag., 2012, vol. 8, pp. 415–427.
Engelking, L.J., McFarlane, M.R., Li, C.K., and Liang, G., J. Lipid Res., 2012, vol. 53, pp. 1359–1368.
Sehayek, E. and Hazen, S.L., Arterioscler. Thromb. Vasc. Biol., 2008, vol. 28, pp. 1296–1297.
Davidson, M.H., McGarry, T., Bettis, R., et al., J. Am. Coll. Cardiol., 2002, vol. 40, pp. 2125–2134.
Kaminnyi, A.I., Lankin, V.Z., Samko, A.N., et al., Byull. Eksper. Biol. Med., 2005, vol. 139, no. 2, pp. 150–152.
Wagner, K.-D. and Wagner, N., Pharmacol. Ther., 2010, vol. 125, pp. 423–435.
Berger, J.P., Akiyama, T.E., and Meinke, P.T., Trends. Pharmacol. Sci., 2005, vol. 26, pp. 244–251.
Colin S., Chinetti-Gbaguidi G., Kuivenhoven J.A., Staels B., Handbook of Experimental Pharmacology, High Density Lipoproteins, Eckardstein A. and Kardassis, D., Eds., Springer, 2015, vol. 224, pp. 617–626.
Chinetti, G., Fruchart, J.C., and Staels, B., Curr. Opin. Lipidol., 2003, vol. 14, pp. 459–468.
Chinetti, G., Lestavel, S., Bocher, V., et al., Nat. Med., 2001, vol. 7, pp. 53–58.
Triolo, M., Annema, W., Boer, J.F., Tietge, U.J., and Dullaart, R.P., Eur. J. Clin. Invest., 2013, vol. 44, pp. 240–248.
Libby, P., Circulation, 2003, vol. 105, pp. 1135–1143.
Wang, T.D., Chen, W.J., Lin, J.W., Cheng, C.C., Chen, M.F., and Lee, Y.T., Atherosclerosis, 2003, vol. 170, pp. 315–323.
Bouhlel, M.A., Derudas, B., Rigamonti, E., et al., Cell Metab., 2007, vol. 6, pp. 137–143.
Oliver, W.R., Shenk, J.L., Snaith, M.R., et al., Proc. Natl. Acad. Sci. USA, 2001, vol. 98, pp. 5306–5311.
Tanaka, T., Yamamoto, J., Iwasaki, S., et al., Proc. Natl. Acad. Sci. USA, 2003, vol. 100, pp. 15924–15929.
Sahebkar, A., Chew, G.T., and Watts, G.F., Expert Opin. Pharmacother., 2014, vol. 15, pp. 493–503.
Enger, C., Gately, R., and Ming, E.E., Am. J. Cardiol., 2010, vol. 106, pp. 1594–1601.
Tontonoz, P., and Spiegelman, B.M., Annu. Rev. Biochem., 2008, vol. 77, pp. 289–312.
Ju, J.G., Javorschi, S., Hevener, A.L., et al., Diabetes, 2002, vol. 51, pp. 2968–2974.
Man’kovskiy, B.N., Ukr. Med. Vestnik, 2008, vol. 22, no. 1.
Dormandy, J.A., Charbonnel, B., Eckland, D.J., et al., Lancet, 2005, vol. 366, pp. 1279–1289.
Campbell, I.W., Br. J. Diabets Vasc. Dis., 2005, vol. 5, pp. 272–274.
Mazzone, T., Meyer, P.M., Feinstein, S.B., et al., J. Am. Med. Ass., 2006, vol. 296, pp. 2572–2581.
Goldberg, R.B., Kendall, D.M., Deeg, M.A., et al., Diabetes Care, 2005, vol. 28, pp. 1547–1554.
Henry, R.R., Lincoff, A.M., Mudaliar, S., Rabbia, M., Chognot, C., and Herz, M., Lancet, 2009, vol. 374, pp. 126–135.
Ishibashi, S., Yamashita, S., Arai, H., Araki, E., Yokote, K., et al., Atherosclerosis, 2016, vol. 249, pp. 36–43.
Arai, H., Yamashita, S., and Yokote, K., Atherosclerosis, 2017, vol. 261, pp. 144–152.
Camejo, G., Atherosclerosis, 2017, vol. 261, pp. 163–164.
Dunn, F.L., Higgins, L.S., Fredrickson, J., and DePaoli, A.M., J. Diabetes Complicat., 2011, vol. 25, pp. 151–158.
http://www.evaluategroup.com/Universal/View.aspx?type=Story&id=203426..
http://www.evaluategroup.com/Universal/View.aspx?type=Story&id=203426..
Fedorova, L.V., Sodhi, K., Gatto-Weis, C., Puri, N., et al., PLoS One, 2013, vol. 8. e64436.
Goto, T., Nakayama, G.T., Yamanaka, M., Takata, M., et al., Exp. Clin. Endocr. Diab., 2015, vol. 123, pp. 492–499.
Cariou, B., Zair, Y., Staels, B., and Bruckert, E., Diabetes Care, 2011, vol. 34, pp. 2008–2014.
Ratziu, V., Stephen, A. Harrison, S.A., Francque, S., Bedossa, P., et al., Gastroenterology, 2016, vol. 150, pp. 1147–1159.
Zhang, L.H., Kamanna, V.S., Ganji, S.H., Xiong, X.M., and Kashyap, M.L., J. Lipid Res., 2012, vol. 53, pp. 941–950.
Morgan, J.M., Capuzzi, D.M., Baksh, R.I., Intenzo, C., Carey, C.M., Reese, D., et al., Am. J. Cardiol., 2003, vol. 91, pp. 1432–1436.
Nicholls, S.J., Cleve. Clin. J. Med., 2012, vol. 79, pp. 38–43.
Lavigne, P.M. and Karas, R.H., J. Am. Coll. Cardiol., 2013, vol. 61, pp. 440–446.
Bays, H.E., Ballantyne, C.M., Kastelein, J.J., Isaacsohn, J.L., Braeckman, R.A., and Soni, P.N., Am. J. Cardiol., 2011, vol. 108, pp. 682–690.
Bäck, M., Future Sci. OA, 2017, vol. 3, no. 4, FSO236. doi 10.4155/fsoa-2017-0067
Arsenault, B.J., Boekholdt, S.M., Tardif, J.C., and Kastelein, J.J., Eur. Heart J., 2012, vol. 33, pp. 1548–1550.
Otocka-Kmiecik, A., Mikhailidis, D.P., Nicholls, S.J., Davidson, M., Rysz, J., and Banach, M., Prog. Lipid. Res., 2012, vol. 51, pp. 314–324.
Paneni, F., Cosentino, F., Marrara, F., Palano, F., Capretti, G., Gregori, M., et al., Int. J. Cardiol., 2012, vol. 158, pp. 158–160.
Wadham, C., Albanese, N., Roberts, J., Wang, L., Bagley, C.J., et al., Circulation, 2004, vol. 109, pp. 2116–2122.
Hafiane, A., Jabor, B., Ruel, I., Ling, J., and Genest, J., Am. J. Cardiol., 2014, vol. 113, pp. 249–255.
Ertek, S., Curr. Vasc. Pharmacol., 2017 [Epub ahead of print]. doi 10.2174/1570161115666171116164612
Burke, A.C., Dron, J.S., Hegele, R.A., and Huff, M.W., Annu. Rev. Pharmacol. Toxicol., 2017, vol. 57, pp. 223–244.
Lagace, T.A., Curr. Opin. Lipidol., 2014, vol. 25, pp. 387–393.
Abifadel, M., Rabès, J.P., Boileau, C., and Varret, M., Ann. Endocrinol. (Paris), 2007, vol. 68, pp. 138–146.
Abifadel, M., Varret, M., Rabes, J.P., et al., Nat. Genet., 2003, vol. 34, pp. 154–156.
Kukharchuk, V.V. and Bazhan, S.S., Ateroskleroz i Dislipidemii, 2013, no. 2, pp. 19–26.
Dietschy, J.M., Turley, S.D., and Spady, D.K., J. Lipid Res., 1993, vol. 34, pp. 1637–1659.
Surdo, P.L., Bottomley, M., Calzetta, A., Settembre, E.C., et al., EMBO Rep., 2011, vol. 12, pp. 1300–1305.
Weinreich, M. and Frishman, W.H., Cardiol. Rev., 2014, vol. 22, no. 3, pp. 140–146.
Robinson, J.G., Farnier, M., Krempf, M., Bergeron, G., et al., New Engl. J. Med., 2015, vol. 372, pp. 1489–1499.
Roth, E.M., McKenney, J.M., Hanotin, C., Asset, G., and Stein, E.A., New Engl. J. Med., 2012, vol. 367, pp. 1891–1900.
Puri, R., Nissen, S.E., Somaratne, R., Cho, L., Kastelein, J.J.P., et al., Am. Heart J., 2016, vol. 176, pp. 83–92.
Nanjee, M.N., Cooke, C.J., Garvin, R., et al., J. Lipid Res., 2001, vol. 42, pp. 1586–1593.
Pownall, H.J. and Ehnholm, C., Curr. Opin. Lipidol., 2005, vol. 16, pp. 265–268.
Markin, S.S., Olbinskaya, L.I., and Torkhovskaya, T.I., Fosfolipidnaya terapiya ateroskleroza (Phospholipid Therapy of Atherosclerosis), Moscow, 2016.
Kudinov, V.A., Ipatova, O.M., Fedorov, I.G., Totolyan, G.G., et al., Biomed. Khim., 2016, vol. 62, pp. 704–707. doi 10.18097/pbmc20166206704
Wójcicka, G., Jamroz-Wiśniewska, A., Horoszewicz, K., and Bełtowskil, J., Postepy Hig. Med. Dosw. (online), 2007, vol. 61, pp. 736–759.
Hong, C. and Tontonoz, P., Nat. Rev. Drug. Discov., 2014, vol. 13, pp. 433–444.
Shih, D.M., Shaposhnik, Z., Meng, Y., Rosales, M., Wang, X., Wu, J., et al., FASEB J., 2013, vol. 27, no. 9, pp. 3805–3817.
Wang, D.Q., Tazuma, S., Cohen, D.E., and Carey, M.C., Am. J. Physiol. Gastrointest. Liver Physiol., 2003, vol. 285, pp. G494–G502.
Camilleri, M. and Gores, G.J., Am. J. Physiol. Gastrointest. Liver Physiol., 2015, vol. 309, pp. G209–G215.
Sato, H., Macchiarulo, A., Thomas, C., Gioiello, A., Une, M., Hofmann, A.F., Saladin, R., et al., J. Med. Chem., 2008, vol. 51, pp. 1831–1841.
Nicholls, S.J., Gordon, A., and Johanson, J., Cardiovasc. Drugs Ther., 2012, vol. 26, pp. 181–187.
Uehara, Y., Ando, S., Yahiro, E., Oniki, K., Ayaori,M., Abe, S., et al., J. Am. Heart. Assoc., 2013, vol. 2. e000048. doi 10.1161/JAHA.113.000048
Miyazaki, A., Sakuma, S., Morikawa, W., Takiue, T., Miake, F., and Terano, T., Arterioscler. Thromb. Vasc. Biol., 1995, vol. 15, pp. 1882–1888.
Ibanez, B., Vilahur, G., Cimmino, G., Speidl, W.S., Pinero, A., Choi, B.G., et al., J. Am. Coll. Cardiol., 2008, vol. 51, pp. 1104–1109.
Cimmino, G., Ibanez, B., Vilahur, G., Speidl, W.S., Fuster, V., Badimon, L., et al., J. Cell Mol. Med., 2009, vol. 13, pp. 3226–3235.
Navab, M., Hough, G., Buga, G.M., Su, F., Wagner, A.C., Meriwether, D., Chattopadhyay, A., et al., J. Lipid Res., 2013, vol. 54, pp. 3403–3418.
Navab, M., Shechter, I., Anantharamaiah, G.M., Reddy, S.T., et al., Arterioscler. Thromb. Vasc. Biol., 2010, vol. 30, pp. 164–168.
Chattopadhyay, A., Navab, M., Hough, G., Gao, F., Meriwether, D., Grijalva, V., et al., J. Lipid Res., 2013, vol. 54, pp. 995–1010.
Lamon-Fava, S., Diffenderfer, M.R., Barrett, P.H., et al., Arterioscler. Thromb. Vasc. Biol., 2008, vol. 28, pp. 1672–1678.
Sviridov, D.D., Karagodin, V.P., Orekhova, V.A., Melnichenko, A.A., and Orekhov, A.N., Patogenez, 2012, vol. 10, no. 2, pp. 4–18.
Picaud, S., Well, C., and Felletar, I., Proc. Natl. Acad. Sci. USA, 2013, vol. 110, pp. 19754–19759.
Bailey, D., Jahagirdar, R., Gordon, A., Hafiane, A., et al., J. Am. Coll. Cardiol., 2010, vol. 55, pp. 2580–2589.
Gilham, D., Wasiak, S., and Tsujikawa, L.M., Atherosclerosis, 2016, vol. 247, pp. 48–57.
https://www.resverlogix.com/programs/rvx-208-clinical-development/#.Wg7J3NSLTGg.
Tardif, J.C., Gregoire, J., L’Allier, P.L., Ibrahim, R., Lesperance, J., Heinonen, T.M., et al., J. Am. Med. Ass., 2007, vol. 297, pp. 1675–1682.
Kingwell, B.A. and Chapman, M.J., Circulation, 2013, vol. 128, pp. 1112–1121.
Badimon, J.J., Badimon, L., and Fuster, V., J. Clin. Invest., 1990, vol. 85, pp. 1234–1241.
Diditchenko, S., Gille, A., Pragst, I., et al., Arteriosler. Thromb. Vasc. Biol., 2013, vol. 33, pp. 2202–2211.
Tardif, J.C., Ballantyne, C.M., Barter, P., Dasseux, J.L., Fayad, Z.A., Guertin, M.C., et al., Eur. Heart J., 2014, vol. 35, pp. 3277–3286.
Keyserling, C.H., Hunt, T.L., Klepp, H.M., Scott, R.A., et al., Circulation, 2011, vol. 124. A15525
Tardy, C., Goffinet, M., Boubekeur, N., Ackermann, R., Sy, G., Bluteau, A., et al., Atherosclerosis, 2014, vol. 232, pp. 110–118.
Kataoka, Y., Andrews, J., Duong, M., et al., Cardiovasc. Diagn. Ther., 2017, vol. 7, pp. 252–263.
Speidl, W.S., Cimmino, G., Ibanez, B., et al., Eur. Heart. J., 2010, vol. 31, pp. 2049–2057.
Nissen, S.E., Tsunoda, T., Tuzcu, E.M., Schoenhagen, P., Cooper, C.J., Yasin, M., et al., J. Am. Med. Ass., 2003, vol. 290, pp. 2292–2300.
Ibanez, B., Giannarelli, C., Cimmino, G., et al., Atherosclerosis, 2012, vol. 220, pp. 72–77.
Kastelein, J.J., Ross, C.J., and Hayden, M.R., Hum. Gene Ther., 2013, vol. 24, no. 5, pp. 472–478.
Gaudet, B., Méthot, J., Déry, S., et al., Gene Therapy, 2013, vol. 20, no. 4, pp. 361–369.
http://uniqure.com/GL_PR_Glybera%20withdrawal_FINAL_PDF.pdf.
Hafiane, A. and Genest, J., Cholesterol, 2013, vol. 2013, article ID 891403. doi 10.1155/2013/891403
Marquart, J., Allen, R.M., Ory, D.S., and Baldán, A., Proc. Natl. Acad. Sci. USA, 2010, vol. 107, pp. 12228–12232.
Kuai, R., Li, D., Chen, Y.E., Moon, J.J., and Schwendeman, A., ACS Nano, 2016, vol. 10, no. 3, pp. 3015–3041.
Wong, E. and Goldberg, T., P&T, 2014, vol. 39, no. 2, pp. 119–122.
Crooke, R.M., Baker, B.F., and Wedel, M., Antisense Drug Technology: Principles, Strategies, and Applications, Crooke, S.T., Ed., 2nd ed., Boca Raton, FL: CRC Press, 2007, pp. 601–639.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © V.A. Kudinov, T.S. Zakharova, T.I. Torkhovskaya, O.M. Ipatova, A.I. Archakov, 2018, published in Biomeditsinskaya Khimiya.
Rights and permissions
About this article
Cite this article
Kudinov, V.A., Zakharova, T.S., Torkhovskaya, T.I. et al. Pharmacological Targets for Correction of Dyslipidemias. Opportunities and Prospects of Therapeutic Use. Biochem. Moscow Suppl. Ser. B 12, 96–113 (2018). https://doi.org/10.1134/S1990750818020075
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1990750818020075